From October 1, 2021 to December 31, 2021, the company has repurchased 1,771,500 shares, representing 0.12% for CNY 24.24 million. With this, the company has completed the repurchase of 3,330,700 shares, representing 0.22% for CNY 45.21 million under the buyback announced on June 26, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.7 CNY | -1.37% | -4.53% | -19.51% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.51% | 2.83B | |
+38.97% | 6.09B | |
-22.28% | 4.14B | |
+3.48% | 3.23B | |
-7.29% | 2.39B | |
+42.43% | 1.9B | |
-4.71% | 1.57B | |
-15.15% | 1.55B | |
-14.86% | 1.5B | |
+38.27% | 1.43B |
- Stock Market
- Equities
- 600535 Stock
- News Tasly Pharmaceutical Group Co., Ltd
- Tranche Update on Tasly Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on June 26, 2021.